- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有32家主力机构披露2025-12-31报告期持股数据，持仓量总计2.57亿股，占流通A股47.33%
- 波段诊断：
-
技术面诊股
诊断结果：5.5技术面打败了54%的股票
技术面评分前10的股票
近期的平均成本为6.81元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为6.81元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.81","date":1775030549,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2026.04.02","stock":"-0.44","trade":null,"ind":"-1.60"},{"date":"2026.04.01","stock":"1.34","trade":null,"ind":"1.70"},{"date":"2026.03.31","stock":"-0.88","trade":null,"ind":"-1.81"},{"date":"2026.03.30","stock":"1.65","trade":null,"ind":"-0.25"},{"date":"2026.03.27","stock":"3.89","trade":null,"ind":"1.13"},{"date":"2026.03.26","stock":"-1.23","trade":null,"ind":"-1.41"},{"date":"2026.03.25","stock":"1.09","trade":null,"ind":"1.95"},{"date":"2026.03.24","stock":"5.58","trade":null,"ind":"1.43"},{"date":"2026.03.23","stock":"-6.31","trade":null,"ind":"-3.76"},{"date":"2026.03.20","stock":"-3.13","trade":null,"ind":"-0.25"},{"date":"2026.03.19","stock":"-3.03","trade":null,"ind":"-2.02"},{"date":"2026.03.18","stock":"1.62","trade":null,"ind":"1.05"},{"date":"2026.03.17","stock":"-0.87","trade":null,"ind":"-1.87"},{"date":"2026.03.16","stock":"0.29","trade":null,"ind":"0.19"},{"date":"2026.03.13","stock":"0.59","trade":null,"ind":"-0.65"},{"date":"2026.03.12","stock":"-1.02","trade":null,"ind":"-0.63"},{"date":"2026.03.11","stock":"-1.29","trade":null,"ind":"0.78"},{"date":"2026.03.10","stock":"1.46","trade":null,"ind":"2.04"},{"date":"2026.03.09","stock":"-0.15","trade":null,"ind":"-0.74"},{"date":"2026.03.06","stock":"2.38","trade":null,"ind":"0.59"},{"date":"2026.03.05","stock":"1.82","trade":null,"ind":"1.23"}]
利德曼,深证成指,医疗器械指数
压力支撑
该股压力位为6.80元，支撑位为6.71元。
[{"text":"\u538b\u529b\u4f4d","value":"6.80","date":1775059200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.71","date":1775059200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.4资金面打败了53%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体无进出。
更新时间：04月02日 16:51
| 机构今日流向(万元) | -922.50 | 机构5日流向(万元) | 611.19 |
| 机构10日流向(万元) | -1951.35 | 机构20日流向(万元) | -5016.64 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少1293.22万股，其中基金净增仓6家，主力净减仓42家，暂未发现中长期投资价值。
截止2025-12-31，共32家主力机构（基金31家，一般法人1家），持仓量总计25706.25万股，占流通A股47.33%
其中，基金持仓与2025-06-30相比：
增仓：10家 ，增持 155.34万股
减仓：4家 ，减持 10.14万股
新出现在主力名单中：17家 ，持有144.58万股
从主力名单中消失：59家 ，原持有1583万股
其中，基金持仓与2025-06-30相比：
增仓：10家 ，增持 155.34万股
减仓：4家 ，减持 10.14万股
新出现在主力名单中：17家 ，持有144.58万股
从主力名单中消失：59家 ，原持有1583万股
消息面诊股
诊断结果：5.9消息面打败了34%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 利德曼（截止2026年3月31日）股东人数为291
2026-04-02 - 利德曼：2026年4月22日召开2025年度股东会
2026-03-30 - 利德曼：董事会审议通过《关于<；2025年度董事会
2026-03-30 - 利德曼全年营业收入3.26亿元，同比下降11.86
2026-03-30 - 利德曼：2025年净亏损2298.31万元
2026-03-30 - 利德曼（截止2026年3月20日）股东人数为281
2026-03-24 - 利德曼（截止2026年3月10日）股东人数为288
2026-03-11 - 利德曼（截止2026年2月27日）股东人数为292
2026-03-02 - 北京利德曼：重大资产重组事项正推进财务数据加期审计
2026-02-28 - 研判2026！中国诊断试剂行业发展历程、产业链、发
2026-02-26
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-31 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-03-31 |
| 利好 | 业绩预告 | 预计减亏 | 2026-01-29 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-21 |
| 一般消息 | 高管变动 | 因工作变动原因 | 2025-09-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了58%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.04.02","price":"-1.60","value":null},{"date":"2026.04.01","price":"1.70","value":null},{"date":"2026.03.31","price":"-1.81","value":null},{"date":"2026.03.30","price":"-0.25","value":null},{"date":"2026.03.27","price":"1.13","value":null},{"date":"2026.03.26","price":"-1.41","value":null},{"date":"2026.03.25","price":"1.95","value":null},{"date":"2026.03.24","price":"1.43","value":null},{"date":"2026.03.23","price":"-3.76","value":null},{"date":"2026.03.20","price":"-0.25","value":null},{"date":"2026.03.19","price":"-2.02","value":null},{"date":"2026.03.18","price":"1.05","value":null},{"date":"2026.03.17","price":"-1.87","value":null},{"date":"2026.03.16","price":"0.19","value":null},{"date":"2026.03.13","price":"-0.65","value":null},{"date":"2026.03.12","price":"-0.63","value":null},{"date":"2026.03.11","price":"0.78","value":null},{"date":"2026.03.10","price":"2.04","value":null},{"date":"2026.03.09","price":"-0.74","value":null},{"date":"2026.03.06","price":"0.59","value":null},{"date":"2026.03.05","price":"1.23","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 九安医疗 | 61.43% | 30.05% | 5.3分 |
| 2 | 海泰新光 | 52.10% | 65.08% | 6.7分 |
| 3 | 力诺药包 | 42.19% | 43.23% | 6.1分 |
| 4 | 康拓医疗 | 40.87% | 4.11% | 5.9分 |
| 5 | 基蛋生物 | 29.72% | 18.33% | 5.6分 |
| 6 | 蓝帆医疗 | 26.15% | 6.91% | 5.5分 |
| 8 | 济民健康 | 18.44% | 15.08% | 5.4分 |
| 10 | 康众医疗 | 14.47% | 15.52% | 5.5分 |
| 12 | 宝莱特 | 14.27% | -0.42% | 4.8分 |
| 14 | 惠泰医疗 | 12.71% | 7.27% | 6.7分 |
| 16 | 中红医疗 | 12.30% | 5.83% | 4.4分 |
| 18 | 微电生理 | 9.52% | 20.81% | 6.0分 |
| 20 | 威高骨科 | 8.60% | 10.52% | 6.0分 |
| 22 | 南卫股份 | 7.42% | -3.41% | 4.9分 |
| 24 | 英诺特 | 7.22% | 0.11% | 3.8分 |
| 26 | 华兰股份 | 6.47% | -2.07% | 5.1分 |
| 28 | 之江生物 | 5.89% | 11.90% | 4.5分 |
| 30 | 万泰生物 | 4.76% | 1.94% | 4.4分 |
| 32 | 亚辉龙 | 4.38% | 0.61% | 4.3分 |
| 34 | 东方生物 | 3.16% | 4.73% | 5.1分 |
| 36 | 冠昊生物 | 3.01% | 7.76% | 5.3分 |
| 38 | 科华生物 | 2.58% | 4.37% | 4.5分 |
| 40 | 开立医疗 | 2.34% | 7.53% | 5.1分 |
| 42 | 万东医疗 | 1.43% | 4.85% | 4.7分 |
| 44 | 海尔生物 | 1.19% | 4.10% | 5.0分 |
| 46 | 利德曼 | 0.89% | 5.61% | 4.8分 |
| 48 | 拱东医疗 | 0.73% | 6.18% | 5.3分 |
| 50 | 春立医疗 | 0.50% | 7.03% | 5.9分 |
| 52 | 安旭生物 | 0.24% | 4.45% | 4.7分 |
| 54 | 美康生物 | 0.00% | 5.84% | 4.6分 |
| 56 | 黄山胶囊 | -0.62% | 2.94% | 6.1分 |
| 58 | 康德莱 | -0.89% | 5.98% | 5.7分 |
| 60 | 透景生命 | -1.16% | 6.45% | 3.5分 |
| 62 | 乐普医疗 | -1.30% | 6.32% | 5.6分 |
| 64 | 九强生物 | -2.02% | 5.19% | 4.5分 |
| 66 | 爱威科技 | -2.14% | 1.42% | 5.3分 |
| 68 | 新华医疗 | -2.56% | 3.13% | 4.9分 |
| 70 | 健尔康 | -2.84% | 3.05% | 4.7分 |
| 72 | 可孚医疗 | -3.26% | 0.27% | 6.0分 |
| 74 | 大博医疗 | -3.57% | 4.07% | 5.2分 |
| 76 | 奥泰生物 | -3.86% | 0.59% | 4.4分 |
| 78 | 洁特生物 | -4.03% | 2.63% | 5.2分 |
| 80 | 威高血净 | -4.59% | 0.90% | 5.4分 |
| 82 | 昊海生科 | -4.62% | 4.18% | 5.8分 |
| 84 | 西山科技 | -4.78% | 4.61% | 5.1分 |
| 86 | 普门科技 | -4.81% | 2.63% | 5.0分 |
| 88 | 康泰医学 | -5.06% | 3.05% | 4.5分 |
| 90 | 乐心医疗 | -5.13% | 1.78% | 5.0分 |
| 92 | 健帆生物 | -5.27% | 1.89% | 4.3分 |
| 94 | 心脉医疗 | -5.50% | -0.07% | 5.2分 |
| 96 | 瑞迈特 | -5.67% | 6.00% | 5.3分 |
| 98 | 新产业 | -5.75% | 0.84% | 5.2分 |
| 100 | 楚天科技 | -5.92% | 4.76% | 5.2分 |
| 102 | - | -6.17% | 9.65% | 分 |
| 104 | 澳华内镜 | -6.45% | 1.46% | 4.3分 |
| 106 | 明德生物 | -6.69% | 6.16% | 4.4分 |
| 108 | 鱼跃医疗 | -6.81% | 1.50% | 5.0分 |
| 110 | 欧普康视 | -7.02% | -0.14% | 4.6分 |
| 112 | 麦澜德 | -7.56% | -0.13% | 4.4分 |
| 114 | 迈瑞医疗 | -7.83% | -1.16% | 5.3分 |
| 116 | - | -8.68% | 6.36% | 分 |
| 118 | - | -9.14% | 2.95% | 分 |
| 120 | - | -9.42% | 5.94% | 分 |
| 122 | 迈普医学 | -9.56% | -0.40% | 5.7分 |
| 124 | 赛科希德 | -10.06% | 2.92% | 4.9分 |
| 126 | 华大智造 | -10.27% | 0.97% | 4.6分 |
| 128 | - | -10.88% | 5.32% | 分 |
| 130 | 采纳股份 | -11.20% | -1.33% | 4.0分 |
| 132 | 麦克奥迪 | -12.10% | 0.57% | 4.7分 |
| 134 | - | -14.12% | 6.30% | 分 |
| 136 | - | -15.26% | 3.08% | 分 |
| 138 | 爱朋医疗 | -16.27% | 0.58% | 3.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 103/242 ， 76/242。
[{"date":"2025-09-30","value":"-0.43","vol":"2.98"},{"date":"2025-06-30","value":"-0.26","vol":"2.34"},{"date":"2025-03-31","value":"-0.08","vol":"1.16"},{"date":"2024-12-31","value":"-4.41","vol":"0.56"},{"date":"2024-09-30","value":"0.06","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.43 | -0.26 | -0.08 | -4.41 | 0.06 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"49.51","vol":"51.74"},{"date":"2025-06-30","value":"52.02","vol":"52.05"},{"date":"2025-03-31","value":"53.56","vol":"51.42"},{"date":"2024-12-31","value":"52.11","vol":"52.52"},{"date":"2024-09-30","value":"54.16","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
49.51 | 52.02 | 53.56 | 52.11 | 54.16 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 94/242 ， 129/242。
[{"date":"2025-09-30","value":"-10.49","vol":"0.26"},{"date":"2025-06-30","value":"-14.80","vol":"-1.09"},{"date":"2025-03-31","value":"-16.61","vol":"-0.12"},{"date":"2024-12-31","value":"-19.79","vol":"1.15"},{"date":"2024-09-30","value":"-17.15","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-10.49 | -14.80 | -16.61 | -19.79 | -17.15 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-765.83","vol":"-15.37"},{"date":"2025-06-30","value":"-800.43","vol":"-18.14"},{"date":"2025-03-31","value":"53.73","vol":"-2.59"},{"date":"2024-12-31","value":"-589.66","vol":"-23.09"},{"date":"2024-09-30","value":"-95.49","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-765.83 | -800.43 | 53.73 | -589.66 | -95.49 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 101/242 ， 65/242。
[{"date":"2025-09-30","value":"0.14","vol":"0.25"},{"date":"2025-06-30","value":"0.09","vol":"0.17"},{"date":"2025-03-31","value":"0.04","vol":"0.08"},{"date":"2024-12-31","value":"0.20","vol":"0.36"},{"date":"2024-09-30","value":"0.15","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.09 | 0.04 | 0.20 | 0.15 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.47","vol":"1.66"},{"date":"2025-06-30","value":"0.85","vol":"1.12"},{"date":"2025-03-31","value":"0.41","vol":"0.55"},{"date":"2024-12-31","value":"2.00","vol":"2.32"},{"date":"2024-09-30","value":"1.40","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.47 | 0.85 | 0.41 | 2.00 | 1.40 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"9.59","vol":"14.74"},{"date":"2025-06-30","value":"-12.03","vol":"15.17"},{"date":"2025-03-31","value":"13.55","vol":"4.22"},{"date":"2024-12-31","value":"17.78","vol":"29.38"},{"date":"2024-09-30","value":"24.13","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 9.59 | -12.03 | 13.55 | 17.78 | 24.13 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.17","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.44","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.17 | - | 0.44 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 122/242 ， 124/242。
[{"date":"2025-09-30","value":"15.03","vol":"5.66"},{"date":"2025-06-30","value":"15.53","vol":"5.47"},{"date":"2025-03-31","value":"15.64","vol":"5.84"},{"date":"2024-12-31","value":"13.63","vol":"5.30"},{"date":"2024-09-30","value":"14.83","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
15.03 | 15.53 | 15.64 | 13.63 | 14.83 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"13.63","vol":"4.51"},{"date":"2025-06-30","value":"13.99","vol":"4.35"},{"date":"2025-03-31","value":"14.15","vol":"4.73"},{"date":"2024-12-31","value":"12.37","vol":"4.27"},{"date":"2024-09-30","value":"11.98","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
13.63 | 13.99 | 14.15 | 12.37 | 11.98 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 126/242 ， 125/242。
[{"date":"2025-09-30","value":"5.33","vol":"22.07"},{"date":"2025-06-30","value":"5.23","vol":"22.01"},{"date":"2025-03-31","value":"5.13","vol":"21.19"},{"date":"2024-12-31","value":"5.70","vol":"21.94"},{"date":"2024-09-30","value":"5.11","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
5.33 | 5.23 | 5.13 | 5.70 | 5.11 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.06","vol":"0.71"},{"date":"2025-06-30","value":"0.06","vol":"0.58"},{"date":"2025-03-31","value":"0.06","vol":"0.56"},{"date":"2024-12-31","value":"0.06","vol":"0.55"},{"date":"2024-09-30","value":"0.06","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"-0.56","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.15","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.75","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.23","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]